Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Industries
Industries
Medical
Products 11 to 20 of 29
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Bacterial toxin promoting tissue healing
by
Friedrich Schiller University Jena
Biotech components:
Bacteria
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (5 years ago)
Date last modified:
2020/12/18 14:39 (5 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Bioengineered mRNA for gene therapy
by
University of Wisconin-Madison
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:36 (5 years ago)
Date last modified:
2020/12/18 14:36 (5 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
Bioengineered Salmonella enterica
by
Prokarium
Biotech components:
Microbe
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (6 years ago)
Date last modified:
2019/09/12 15:18 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
COVID-19 Antibody Treatment
by
Adagio
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (5 years ago)
Date last modified:
2020/12/18 14:39 (5 years ago)
Known funding amount:
50,000,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
crPhage
by
Locus Biosciences
Biotech components:
Gene Editing
+
Molecule
+
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (6 years ago)
Date last modified:
2019/09/12 15:10 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Health
+
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Endocannabinoids for intestinal infection treatment
by
University of Texas Southwestern Medical Center
Biotech components:
Molecule
+
Plant
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (5 years ago)
Date last modified:
2020/12/18 14:39 (5 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Epidiolex
by
EPIDIOLEX
Biotech components:
N/A
Business models:
B2B
Country of production:
N/A
Country of distribution:
USA
Intended consumer:
Commercial
+
Consumer
Date added:
2019/04/01 10:02 (6 years ago)
Date last modified:
2019/04/12 09:32 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Gen 3 technical and medical fiber
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
1,200,000 USD
Funding types:
Shareholder Investment
+
Government
Industry:
Medical
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Web search
Trading symbol:
KBLB
(OTCQB)
Value chain stage:
Input
GM Yeast to make Cannabis
by
University of California, Berkeley
+
Demetrix Inc.
Biotech components:
Yeast
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:18 (6 years ago)
Date last modified:
2019/09/12 15:18 (6 years ago)
Known funding amount:
11,000,000 USD
Funding types:
Venture Capital
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
+
University
Product categories:
Medicine
Production process:
N/A
Source:
Scientist Magazine
Trading symbol:
N/A
Value chain stage:
Input
implanted device to control bladder function
by
Biotech components:
Animal
+
Molecule
Business models:
N/A
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/04/01 10:01 (6 years ago)
Date last modified:
2019/04/12 09:36 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
Under Development
+
More information needed
Organization type(s):
N/A
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
